Market Overview

UPDATE: Jefferies Reiterates Buy Rating, Lowers PT on Shire PLC on 2013 EPS

Share:
Related
Could M&A Boost Pfizer More? Jefferies Thinks So
Benzinga's M&A Chatter for Thursday May 21, 2015
Is Shire A Takeover Target For Pfizer? (Seeking Alpha)

In a report published Wednesday, Jefferies reiterated its Buy rating on Shire PLC (NASDAQ: SHPG), but lowered its price target from $117.00 to $112.00.

Jefferies noted, “We remain 3% shy of 2013E cons. EPS and Shire's +10% YoY aim, largely on more cautious sales notably AXR. Still this doesn't detract from our thesis that significant Phase II-III pipeline news this year should boost belief in long-term organic growth prospects. Near-term R&D spend can be justified whilst SG&A leverage delivers a robust +12% 2013-16E CAGR at a minimum, supporting a re-rating from the current paltry 13x 2014E.”

Shire PLC closed on Tuesday at $95.67.

Latest Ratings for SHPG

DateFirmActionFromTo
Apr 2015Exane BNP ParibasInitiates Coverage onOutperform
Mar 2015BernsteinUpgradesMarket PerformOutperform
Mar 2015Leerink SwannMaintainsMarket Perform

View More Analyst Ratings for SHPG
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (SHPG)

Around the Web, We're Loving...